You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Inadequately controlled asthma, brodalumab, AMG 827

Showing 1 - 25 of 4,736
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Rheumatoid Arthritis Trial (Brodalumab, Placebo, Methotrexate)

Completed
Has Results
  • Rheumatoid Arthritis
  • (no location specified)
Nov 22, 2021

Asthma Trial in Worldwide (AMG 827, Placebo)

Completed
Has Results
  • Asthma
  • AMG 827
  • Placebo
  • Encinitas, California
  • +48 more
Oct 29, 2021

Rheumatoid Arthritis Trial (Brodalumab, Placebo)

Completed
Has Results
  • Rheumatoid Arthritis
  • Brodalumab
  • Placebo
  • (no location specified)
Oct 29, 2021

Asthma Trial in Worldwide (Placebo, Brodalumab)

Terminated
Has Results
  • Asthma
  • Placebo
  • Brodalumab
  • Birmingham, Alabama
  • +160 more
Feb 3, 2022

Crohn's Disease Trial in Worldwide (Brodalumab, Placebo)

Terminated
Has Results
  • Crohn's Disease
  • Brodalumab
  • Placebo
  • Birmingham, Alabama
  • +50 more
Dec 1, 2021

Crohn's Disease Trial in Worldwide (Brodalumab)

Terminated
Has Results
  • Crohn's Disease
  • Brodalumab
  • Birmingham, Alabama
  • +33 more
Nov 30, 2021

Rheumatoid Arthritis Trial in Worldwide (AMG 827)

Terminated
Has Results
  • Rheumatoid Arthritis
  • AMG 827
  • Scottsdale, Arizona
  • +43 more
Feb 3, 2022

Psoriatic Arthritis Trial in Worldwide (210 mg brodalumab, 140 mg brodalumab, Placebo)

Completed
Has Results
  • Psoriatic Arthritis
  • 210 mg brodalumab
  • +2 more
  • Peoria, Arizona
  • +102 more
Aug 8, 2020

Eosinophilic Asthma, Asthma; Eosinophilic, Asthma Trial in United States (Dexpramipexole DiHCl, Placebo)

Recruiting
  • Eosinophilic Asthma
  • +2 more
  • Dexpramipexole Dihydrochloride
  • Placebo
  • West Covina, California
  • +7 more
Mar 1, 2023

Eosinophilic Asthma, Asthma; Eosinophilic, Asthma Trial in Jacksonville (Dexpramipexole DiHCl, Placebo)

Recruiting
  • Eosinophilic Asthma
  • +2 more
  • Dexpramipexole Dihydrochloride
  • Placebo
  • Jacksonville, Florida
    Research Site 30001-291
Apr 17, 2023

Eosinophilic Asthma, Asthma; Eosinophilic, Asthma Attack Trial in United States (Dexpramipexole DiHCl, Placebo)

Recruiting
  • Eosinophilic Asthma
  • +2 more
  • Dexpramipexole Dihydrochloride
  • Placebo
  • West Covina, California
  • +7 more
Mar 1, 2023

Psoriatic Arthritis Trial in Canada, United States (AMG 827 140, Placebo, AMG 827 280)

Terminated
Has Results
  • Psoriatic Arthritis
  • AMG 827 140
  • +3 more
  • Peoria, Arizona
  • +30 more
Aug 19, 2020

Asthma Trial in Worldwide (BFF MDI 160/9.6 µg BID (320/19.2µg/day), BD MDI 160 µg BID (320 µg/day))

Recruiting
  • Asthma
  • BFF MDI 160/9.6 μg BID (320/19.2μg/day)
  • BD MDI 160 μg BID (320 μg/day)
  • Huntington Beach, California
  • +52 more
Mar 9, 2023

Asthma Trial in Worldwide (BGF MDI 320/28.8/9.6 µg, BGF MDI 320/14.4/9.6 µg, BFF MDI 320/9.6 µg)

Recruiting
  • Asthma
  • BGF MDI 320/28.8/9.6 μg
  • +3 more
  • Birmingham, Alabama
  • +423 more
Jan 18, 2023

Asthma Trial in Worldwide (BGF MDI 320/28.8/9.6 µg, BGF MDI 320/14.4/9.6 µg, BFF MDI 320/9.6 µg)

Recruiting
  • Asthma
  • BGF MDI 320/28.8/9.6 μg
  • +3 more
  • Muscle Shoals, Alabama
  • +387 more
Jan 18, 2023

Psoriasis Vulgaris Trial in Belgium (Venapuncture, Patient questionnaires)

Recruiting
  • Psoriasis Vulgaris
  • Venapuncture
  • Patient questionnaires
  • Ghent, Oost-Vlaanderen, Belgium
  • +6 more
Jan 16, 2023

Psoriasis Vulgaris Trial in Valencia (Brodalumab)

Recruiting
  • Psoriasis Vulgaris
  • Brodalumab
  • Brussels, Belgium
  • +21 more
Dec 12, 2022

Asthma Trial in Worldwide (BFF MDI 320/9.6 µg, BFF MDI 160/9.6 µg, BD MDI 320 µg)

Recruiting
  • Asthma
  • BFF MDI 320/9.6 μg
  • +3 more
  • Saraland, Alabama
  • +121 more
Aug 22, 2022

Asthma Trial in China (FF/VI, FF/UMEC/VI, ELLIPTA)

Recruiting
  • Asthma
  • Xiamen, Fujian, China
  • +40 more
Oct 25, 2022

Psoriasis Trial in Barcelona, Granada, Pontevedra (Brodalumab, Ustekinumab, Placebo)

Recruiting
  • Psoriasis
  • Brussels, Bruxelles-Capitale, Belgium
  • +21 more
Jan 27, 2023

Severe Asthma Trial in Japan (Biological: Experimental: Tezepelumab)

Completed
Has Results
  • Severe Asthma
  • Biological: Experimental: Tezepelumab
  • Chuo-ku, Japan
  • +4 more
May 9, 2022

Plaque Psoriasis, Psoriasis Vulgaris, Psoriasis Trial in Worldwide (Brodalumab, Placebo, Guselkumab)

Completed
  • Plaque Psoriasis
  • +2 more
  • Brodalumab
  • +2 more
  • Wien, Austria
  • +52 more
Jan 11, 2023

Asthma, Bronchial Diseases, Respiratory Tract Diseases Trial in Worldwide (Tezepelumab, Placebo)

Completed
Has Results
  • Asthma
  • +8 more
  • Tezepelumab
  • Placebo
  • Denver, Colorado
  • +27 more
Feb 18, 2022

Relapsed/Refractory Multiple Myeloma Trial in Worldwide (AMG 701, Pomalidomide, Dexamethasone)

Active, not recruiting
  • Relapsed/Refractory Multiple Myeloma
  • AMG 701
  • +2 more
  • Scottsdale, Arizona
  • +33 more
Nov 29, 2022

Hidradenitis Suppurativa, Acne Inversa Trial in New York (Brodalumab)

Completed
  • Hidradenitis Suppurativa
  • Acne Inversa
  • New York, New York
    The Rockefeller University
Jul 26, 2022